Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
A study by the Brain Institute (ICM/Inserm/CNRS/Sorbonne University/AP-HP) establishes for the first time the link between the onset of cognitive fatigue and the accumulation of a neurotransmitter called glutamate in a particular region of the brain...
Researchers and clinicians from the research team co-directed by Prof. Marc SANSON and Emmanuelle HUILLARD at the Paris Brain Institute have just identified four molecular profiles of primary central nervous system lymphoma (PCNSL) that could predict...
The team " Plasticity and regeneration of myelin" co-directed by Brahim NAIT-OUMESMAR, Inserm Research Director at the Paris Brain Institute - in collaboration with Angela Giangrande's team (IGBMC, Illkirch) has just demonstrated that the Gcm2 gene...
In everyday life, we all need to anticipate our actions. On the road, for example, we need to start or cross when the light turns green. While the light is red, our brain prepares to act as quickly as possible as soon as the color changes because we...
A research team from Inserm, CNRS, Sorbonne University and AP-HP at the Paris Brain Institute in Paris just deciphered how our brain behaves when we procrastinate. The study, conducted in humans, combines functional imaging and behavioral testing. It...
Transcranial Magnetic Stimulation (TMS) is a non-invasive stimulation procedure that uses transient electromagnetic fields to act in a focused manner on a particular brain region. It can be used as a therapy for depression, Parkinson's disease or...
Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...
A research team from the Paris Brain Institute (Inserm/CNRS/Sorbonne University/AP-HP) just identified mutations in familial cases with early-onset Parkinsonism and intellectual disability. Genetic studies on two affected siblings pairs highlighted...
The diagnosis of atypical forms of Alzheimer's disease is still sometimes difficult. Researchers from Paris Brain Institute have developed an automated algorithm to correlate the specificities of brain lesions with the symptoms associated with these...
In a recent paper, published in Reviews of Modern Physics, Charley Presigny and Fabrizio de Vico Fallani (Inria) from the ARAMIS team from the Paris Brain Institute present a new mathematical model to decipher the brain organization and function in...
